Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib for prevention or mitigation of postoperative delirium in elderly orthopedic ICU patients
ChiCTR1800019988Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of parecoxib in postoperative delirium (POD) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Delirium score. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
parecoxib
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR1800019988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019988.